OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of Mitochondria in the Chemoresistance of Pancreatic Cancer Cells
Yibo Fu, Francesca Ricciardiello, Gang Yang, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 497-497
Open Access | Times Cited: 40

Showing 26-50 of 40 citing articles:

Tumor-derived exosome PPP3CB induce gemcitabine resistance by regulating miR-298/STAT3 in pancreatic cancer
Chaojun Wang, Shengqian Xu, Yong Qin
Heliyon (2024) Vol. 10, Iss. 16, pp. e36434-e36434
Open Access | Times Cited: 1

Role of Sphingosine-1-Phosphate Signaling Pathway in Pancreatic Diseases
Fei Fu, Wanmeng Li, Xiaoyin Zheng, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11474-11474
Open Access | Times Cited: 1

Macrophage C/EBPδ Drives Gemcitabine, but Not 5-FU or Paclitaxel, Resistance of Pancreatic Cancer Cells in a Deoxycytidine-Dependent Manner
C. Arnold Spek, Hella L. Aberson, JanWillem Duitman
Biomedicines (2022) Vol. 10, Iss. 2, pp. 219-219
Open Access | Times Cited: 7

Mitofusin-2 in cancer: Friend or foe?
Pushpamala Ramaiah, Indrajit Patra, Anum Abbas, et al.
Archives of Biochemistry and Biophysics (2022) Vol. 730, pp. 109395-109395
Closed Access | Times Cited: 5

Bromo- and Extra-Terminal Domain Inhibitors Induce Mitochondrial Stress in Pancreatic Ductal Adenocarcinoma
Manjul Rana, Rita G. Kansal, Bijay Bisunke, et al.
Molecular Cancer Therapeutics (2023) Vol. 22, Iss. 8, pp. 936-946
Open Access | Times Cited: 2

Cancer Metabolism as a New Real Target in Tumor Therapy
Ferdinando Chiaradonna, Domenica Scumaci
Cells (2021) Vol. 10, Iss. 6, pp. 1393-1393
Open Access | Times Cited: 5

Recent advancement in molecular markers of pancreatic cancer
L. Tharrun Daniel Paul, Ganesh Munuswamy‐Ramanujam, Rajappan Chandra Satish Kumar, et al.
Elsevier eBooks (2024), pp. 121-149
Closed Access

Intracellular Compartments and Drug Resistance
Safiya Mehraj, Shariqa Jan, Kaneez Fatima, et al.
(2024), pp. 269-295
Closed Access

Molecular Identification of Predatory Birds Through Analysis of Mitochondrial ND2 Gene
Rumisha Raza, Ali Raza Awan, Muhammad Wasim, et al.
Pakistan Journal of Zoology (2023) Vol. 56, Iss. 4
Open Access | Times Cited: 1

STOML2 Restricts Mitophagy and Increases Chemosensitivity in Pancreatic Cancer through Stabilizing PARL-induced PINK1 degradation
Cheng‐Feng Qin, Yuanyang Wang, Bangbo Zhao, et al.
Research Square (Research Square) (2022)
Closed Access | Times Cited: 2

Identification of chemotherapy targets reveals a nucleus-to-mitochondria ROS sensing pathway
Junbing Zhang, Claire Simpson, Jacqueline Berner, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access

Nanotubes and fullerene as efficient nanocarriers for delivery of mitocans to hexokinase 2: An in-silico approach
Geeta Swargiary, Shalini Mani
Materials Today Proceedings (2022) Vol. 76, pp. 359-364
Closed Access

Previous Page - Page 2

Scroll to top